Total Payments
$47,480
2024 Payments
$2,250
Companies
6
Transactions
58
Payment Breakdown by Category
Other$22,418 (47.2%)
Consulting$11,325 (23.9%)
Education$6,886 (14.5%)
Travel$2,675 (5.6%)
Food & Beverage$2,137 (4.5%)
Research$2,040 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $22,418 | 14 | 47.2% |
| Consulting Fee | $11,325 | 6 | 23.9% |
| Education | $6,886 | 8 | 14.5% |
| Travel and Lodging | $2,675 | 9 | 5.6% |
| Food and Beverage | $2,137 | 20 | 4.5% |
| Unspecified | $2,040 | 1 | 4.3% |
Payments by Type
General
$45,440
57 transactions
Research
$2,040
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Agios Pharmaceuticals, Inc. | $45,863 | 44 | $0 (2024) |
| BioMarin Pharmaceutical Inc. | $904.54 | 3 | $0 (2019) |
| Spark Therapeutics, Inc. | $248.52 | 2 | $0 (2022) |
| Novo Nordisk Inc | $225.89 | 7 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $122.04 | 1 | $0 (2019) |
| Genentech USA, Inc. | $115.60 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,250 | 5 | Agios Pharmaceuticals, Inc. ($2,250) |
| 2023 | $4,645 | 9 | Agios Pharmaceuticals, Inc. ($4,645) |
| 2022 | $5,830 | 11 | Agios Pharmaceuticals, Inc. ($5,705) |
| 2020 | $13,129 | 10 | Agios Pharmaceuticals, Inc. ($13,005) |
| 2019 | $2,672 | 6 | Agios Pharmaceuticals, Inc. ($1,530) |
| 2018 | $18,826 | 13 | Agios Pharmaceuticals, Inc. ($18,729) |
| 2017 | $129.08 | 4 | Novo Nordisk Inc ($129.08) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $123.46 | General |
| Category: Genetically Defined Disease | ||||||
| 12/06/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: Genetically Defined Disease | ||||||
| 08/14/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Genetically Defined Disease | ||||||
| 07/10/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | — | Cash or cash equivalent | $2,040.00 | Research |
| Study: Investigator Sponsored Trial • Category: Genetically Defined Disease | ||||||
| 04/17/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: Genetically Defined Disease | ||||||
| 12/11/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Honoraria | Cash or cash equivalent | $1,387.50 | General |
| Category: Genetically Defined Disease | ||||||
| 12/09/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Genetically Defined Disease | ||||||
| 10/18/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $48.66 | General |
| Category: Genetically Defined Disease | ||||||
| 08/16/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Honoraria | Cash or cash equivalent | $1,110.00 | General |
| Category: Genetically Defined Disease | ||||||
| 06/23/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Honoraria | Cash or cash equivalent | $1,942.50 | General |
| Category: Genetically Defined Disease | ||||||
| 06/01/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $33.34 | General |
| Category: Genetically Defined Disease | ||||||
| 02/08/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: Genetically Defined Disease | ||||||
| 01/28/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $31.26 | General |
| Category: Genetically Defined Disease | ||||||
| 01/12/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $36.87 | General |
| Category: Genetically Defined Disease | ||||||
| 12/10/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $135.94 | General |
| Category: Genetically Defined Disease | ||||||
| 12/07/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Honoraria | Cash or cash equivalent | $637.50 | General |
| Category: Genetically Defined Disease | ||||||
| 11/10/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Travel and Lodging | Cash or cash equivalent | $70.54 | General |
| Category: Genetically Defined Disease | ||||||
| 11/09/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Travel and Lodging | Cash or cash equivalent | $427.32 | General |
| Category: Genetically Defined Disease | ||||||
| 11/09/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $295.00 | General |
| Category: Genetically Defined Disease | ||||||
| 11/09/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Travel and Lodging | Cash or cash equivalent | $97.04 | General |
| Category: Genetically Defined Disease | ||||||
| 11/04/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Honoraria | Cash or cash equivalent | $1,020.00 | General |
| Category: Genetically Defined Disease | ||||||
| 10/21/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Travel and Lodging | Cash or cash equivalent | $351.31 | General |
| Category: Genetically Defined Disease | ||||||
| 06/30/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Honoraria | Cash or cash equivalent | $1,020.00 | General |
| Category: Genetically Defined Disease | ||||||
| 06/22/2022 | Spark Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 03/23/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: Genetically Defined Disease | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Investigator Sponsored Trial | Agios Pharmaceuticals, Inc. | $2,040 | 1 |
About Dr. Bertil Glader, MD
Dr. Bertil Glader, MD is a Pediatric Hematology-Oncology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1417082272.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bertil Glader, MD has received a total of $47,480 in payments from pharmaceutical and medical device companies, with $2,250 received in 2024. These payments were reported across 58 transactions from 6 companies. The most common payment nature is "Honoraria" ($22,418).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Palo Alto, CA
- Active Since 02/22/2007
- Last Updated 03/24/2008
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1417082272
Products in Payments
- PYRUKYND (Drug) $12,600
- ULTOMIRIS (Drug) $122.04
- HEMLIBRA (Biological) $115.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Palo Alto
Philip Pizzo, Md, MD
Pediatric Hematology-Oncology — Payments: $2.6M
Pediatric Hematology-Oncology $2.6M
Christopher Dvorak, Md, MD
Pediatric Hematology-Oncology — Payments: $125,679
Pediatric Hematology-Oncology $125,679
Dr. John Curnutte, M.d., Ph.d, M.D., PH.D
Pediatric Hematology-Oncology — Payments: $49,859
Pediatric Hematology-Oncology $49,859
Glaivy Batsuli, Md, MD
Pediatric Hematology-Oncology — Payments: $43,490
Pediatric Hematology-Oncology $43,490
Michael Link, Md, MD
Pediatric Hematology-Oncology — Payments: $42,188
Pediatric Hematology-Oncology $42,188
Orly Klein, Md, MD
Pediatric Hematology-Oncology — Payments: $31,152
Pediatric Hematology-Oncology $31,152